Sun Pharma acquires Organon
Sun Pharma agreed to acquire Organon. Reported deal value: $10B. Status: Speculative. Sector: Pharmaceutical. Target headquarters context: Jersey City, New Jersey, United States.
This page summarizes publicly available information about the transaction as of 2026-01-20. Figures and status may change as filings and press coverage update.
Sun Pharmaceutical Evaluates Organon Acquisition to Scale US Business Sun Pharmaceutical Evaluates Organon Acquisition to Scale US Business By - January 20, 2026 Sun Pharmaceutical Industries , India largest drugmaker by market capitalisation and revenue, is reportedly evaluating the acquisition of US-based Organon , a company focused on women health with a rapidly expanding presence in the biosimilars market
Deal timeline
This transaction is classified in Pharmaceutical with a reported deal value of $10B. Figures and status may change as sources update.